Cytogenetics are a predictive factor of response to low dose Ara-C in acute myelogenous leukemia (AML) in the elderly

Leukemia. 1990 Apr;4(4):312.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged*
  • Cytarabine / therapeutic use*
  • Female
  • Gene Rearrangement
  • Humans
  • Karyotyping
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / genetics*
  • Male
  • Middle Aged

Substances

  • Cytarabine